Trials / Sponsors / Medytox Korea
Medytox Korea
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Long-term Extension Study to Evaluate MBA-P01 in Subjects With Moderate to Severe Glabellar Lines Glabellar Frown Lines | Phase 3 | 2022-02-07 |
| Completed | A Phase II Study to Evaluate the Efficacy and Safety of MBA-P01 in Subjects With Moderate to Severe Glabellar Glabellar Frown Lines | Phase 2 | 2021-12-28 |
| Completed | Study to Evaluate the Efficacy and Safety of MBA-P01 in Subjects With Glabellar Lines Glabellar Frown Lines | Phase 3 | 2021-08-30 |